MCT System · Add-on
Exo-Tech
An injectable autologous matrix combining Plasma Gel with PRP enriched with the patient’s own platelet-derived exosomes.
What it does
Exo-Tech: An autologous scaffold designed to support local retention of platelet-derived extracellular vesicles.
Plasma gel alone is structural. Exo-Tech Gel adds the biological signal.
Plasma Gel scaffold
Platelet-poor plasma (PPP) thermally processed into a three-dimensional protein-based matrix that provides structural support and a framework for incorporating biological components.
MCT Exosomes
PRP photothermally biomodulated using the Exosomes preset to promote the release of platelet-derived exosomes.
Fully autologous
Both components are obtained from the patient’s own blood in a single blood draw, without the addition of synthetic polymers.
Inside Exo-Tech Gel
MCT Exosomes in a Plasma Gel scaffold
A three-dimensional protein network that incorporates MCT Exosomes, combining the structural properties of plasma gel with platelet-derived exosomes and growth factors to support their local retention.
Sustained release potential
The plasma gel acts as a local reservoir for MCT Exosomes, with the potential to support the gradual release of bioactive components over time.
Matrix-mediated protection
The three-dimensional protein network provides a supportive environment for incorporated bioactive components, potentially limiting their early dispersion and degradation.
Complementary action
Structural support from the plasma gel scaffold, combined with the biological signalling potential of MCT Exosomes.
Fully autologous
Fully autologous, without added synthetic polymers. The plasma gel is naturally biodegradable, with related heat-treated plasma formulations showing persistence for up to 3–6 months.
The system
Built on the MCT System
Exo-Tech combines two complementary technologies: the MCT System conditions PRP to obtain MCT Exosomes, while the Exo-Tech Dry Bath prepares the autologous plasma gel scaffold.
Add-on
Exo-Tech Dry Bath
A controlled heating program at 90 °C transforms platelet-poor plasma (PPP) into a viscoelastic plasma gel.
Plasma gel
Core technology
MCT System
Photothermal biomodulation with the Exosomes preset promotes the release of platelet-derived exosomes, obtaining MCT Exosomes.
MCT Exosomes
The protocol
Three steps at the point of care
One blood draw, two syringes: plasma gel prepared from PPP and MCT Exosomes obtained from PRP, combined to form Exo-Tech Gel.
Plasma gel
PPP is thermally processed in the Exo-Tech Dry Bath at 90 °C to form a viscoelastic protein-based gel, which is then cooled to 37 °C or below before mixing.
MCT Exosomes
PRP from the same blood draw undergoes photothermal conditioning using the MCT Exosomes preset.
Exo-Tech Gel
Both preparations are connected using a Luer-lock connector and mixed until homogeneous, obtaining Exo-Tech Gel ready for clinical application.
Heating time determines gel consistency
Under controlled heating conditions, exposure time influences protein structuring and determines the final consistency of the plasma gel.
- 3 minSoft More fluid consistency, allowing easier spreading.
- 6 minIntermediate Balanced consistency between fluidity and structural support.
- 9 minFirm Greater firmness and cohesiveness for increased structural support.
Scientific background
Scientific foundations of Exo-Tech
Published research on MCT Exosomes, autologous plasma gel and hydrogel-based exosome delivery provides the scientific rationale behind Exo-Tech. These publications investigate the individual components and related technologies, rather than the combined Exo-Tech Gel preparation.
Autologous platelet-rich plasma exosome quantification after two thermo-photobiomodulation protocols with different fluences
Journal of Photochemistry and Photobiology · 2025 — Laura Cordero, Joan Carles Domingo, Elena Sánchez-Vizcaíno Mengual, Hernán Pinto
MCT Exosomes research
Assessment of the efficacy and safety of platelet poor plasma gel as autologous dermal filler for facial rejuvenation
Journal of Cosmetic Dermatology · 2019 — Doghaim NN, El-Tatawy RA, Neinaa YME
Autologous Plasma Gel research
Platelet-poor plasma gel vs platelet-rich plasma for infraorbital rejuvenation: a clinical and dermoscopic comparative study
Dermatologic Therapy · 2020 — Neinaa YME, Hodeib AAE, Morquos MM, Elgarhy LH
Autologous Plasma Gel research
In vivo assessment of plasma gel: regenerative potential and limitations as a filler
Journal of Cosmetic Dermatology · 2025 — Cheng H, Li J, Zhao Y, Xia X, Li Y
Autologous Plasma Gel research
Hydrogel-exosome system in tissue engineering: a promising therapeutic strategy
Bioactive Materials · 2024 — Fan MH, Pi JK, Zou CY, et al.
Hydrogel-based exosome delivery
Hydrogels for exosome delivery in biomedical applications
Gels · 2022 — Xie Y, Guan Q, Guo J, Chen Y, Yin Y, Han X
Hydrogel-based exosome delivery
Clinical FAQs
A 15-page guide for clinicians
Preparation, density selection, injection technique and safety. Request it with the form below; some of the questions it answers:
- How does Exo-Tech Gel differ from plasma gel alone?
- Do the 3-, 6- and 9-minute values represent concentration?
- How should plasma gel density be selected?
- Is there a risk of vascular occlusion, and how is it managed?
- Can Exo-Tech Gel be combined with HA fillers in the same session?
Exo-Tech in Practice: Answers to the Most Common Clinical Questions
